Scientists from the National University of Singapore have developed an innovative catalyst that achieves a significantly lower carbon footprint, paving the way for greener chemical and pharmaceutical manufacturing processes.
Tag: Pharmaceutical Manufacturing
Enterprise Risk Consortium Forthcoming from UMD Smith
Risk management expert Clifford Rossi to lead initiative targeting risk practitioners in response to evolving climate change events and recent bank failures.
ILAE survey highlights global concerns about generic anti-seizure medications
Neurologists worldwide have concerns about the use of generic anti-seizure medications, including poor or inconsistent quality, limited access, cost, and lack of regulatory control, according to a global survey of health care professionals.
Mitigating Drug Shortages via a Quality Management Rating System is Viable: New Study
A “quality management maturity” (QMM) rating system for pharmaceutical manufacturing facilities is viable toward reducing drug shortages and increasing medicine availability, according to research by risk management expert Clifford Rossi at the University of Maryland.